Pharmaron Beijing Co., Ltd. (03759) disclosed that, as of October 31, 2025, the authorized share capital consisted of 301,537,125 H shares (par value RMB 1) and 1,476,658,400 A shares (par value RMB 1), totaling RMB 1,778,195,525. There were no changes in the number of authorized or issued shares for both H and A shares within the month.

The report indicated 301,537,125 H shares issued, of which 7,263,300 were held in treasury. These treasury shares remain designated for the 2025 H Share Award and Trust Scheme, approved on June 20, 2025. The 1,476,658,400 A shares showed no movement in treasury during the period.

Pharmaron Beijing Co., Ltd. continues to manage several A share incentive schemes adopted in recent years, although no new A shares were issued or transferred out of treasury during the reporting period. By the end of October 2025, the company reported no changes in its total issued share capital or treasury shareholdings.